Bellevue Life Sciences Acquisition Corp.
BLAC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $6,176 | -$14,596 | -$11,393 | -$2,022 |
| Dep. & Amort. | -$0 | $1 | $0 | $0 |
| Deferred Tax | -$1,295 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $1,754 | -$1,754 | $0 | $0 |
| Other Non-Cash | -$9,785 | $16,305 | $11,328 | $1,519 |
| Operating Cash Flow | -$3,150 | -$44 | -$64 | -$503 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$50 | $50 | $0 | $0 |
| Inv. Sales/Matur. | $19,323 | -$19,323 | $0 | $0 |
| Other Inv. Act. | -$2,212 | $957 | $1,186 | $18,973 |
| Investing Cash Flow | $17,061 | -$18,316 | $1,186 | $18,973 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$1,778 |
| Stock Issued | $3,385 | $0 | $0 | $0 |
| Stock Repurch. | -$19,186 | $19,186 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$14,450 | $19,457 | $149 | -$33,684 |
| Financing Cash Flow | -$14,450 | $19,457 | $149 | -$18,416 |
| Forex Effect | -$68 | $92 | -$17 | $0 |
| Net Chg. in Cash | $593 | $1,518 | $1,254 | $54 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,584 | $66 | $342 | $12 |
| End Cash | $2,177 | $1,584 | $1,596 | $66 |
| Free Cash Flow | -$3,150 | -$44 | -$64 | -$503 |